LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 2 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 2. - Dataset (ID:20310)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 63.15 | 17.25 | 2 | 5061 | 0.0004 | -0.2312 | MN20160310_N02 | G14 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 63.15 | 17.25 | 9427 | 5061 | 1.8626 | 1.1577 | MN20160310_N02 | G14 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 63.15 | 17.25 | 8 | 5061 | 0.0016 | -0.0895 | MN20160310_N02 | H15 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 63.15 | 17.25 | 9316 | 5061 | 1.8407 | 1.1546 | MN20160310_N02 | H15 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 65.12 | 17.25 | 3926 | 5095 | 0.7705 | 0.9375 | MN20160310_N02 | D03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 65.12 | 17.25 | 7290 | 5095 | 1.4308 | 1.0892 | MN20160310_N02 | D03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 65.12 | 17.25 | 971 | 5095 | 0.1906 | 0.6342 | MN20160310_N02 | D05 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 65.12 | 17.25 | 7431 | 5095 | 1.4584 | 1.0941 | MN20160310_N02 | D05 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 65.12 | 17.25 | 3 | 5095 | 0.0006 | -0.1920 | MN20160310_N02 | G14 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 65.12 | 17.25 | 9945 | 5095 | 1.9518 | 1.1698 | MN20160310_N02 | G14 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 65.12 | 17.25 | 5 | 5095 | 0.0010 | -0.1401 | MN20160310_N02 | H15 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 65.12 | 17.25 | 9701 | 5095 | 1.9039 | 1.1633 | MN20160310_N02 | H15 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 67.09 | 17.25 | 3642 | 5221 | 0.6976 | 0.9145 | MN20160310_N02 | D03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 67.09 | 17.25 | 7575 | 5221 | 1.4509 | 1.0924 | MN20160310_N02 | D03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 67.09 | 17.25 | 917 | 5221 | 0.1756 | 0.6195 | MN20160310_N02 | D05 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 67.09 | 17.25 | 7793 | 5221 | 1.4926 | 1.0996 | MN20160310_N02 | D05 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 67.09 | 17.25 | 2 | 5221 | 0.0004 | -0.2301 | MN20160310_N02 | G14 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 67.09 | 17.25 | 10244 | 5221 | 1.9621 | 1.1704 | MN20160310_N02 | G14 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 67.09 | 17.25 | 5 | 5221 | 0.0010 | -0.1395 | MN20160310_N02 | H15 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 67.09 | 17.25 | 10150 | 5221 | 1.9441 | 1.1680 | MN20160310_N02 | H15 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 69.06 | 17.25 | 3312 | 5242 | 0.6317 | 0.8917 | MN20160310_N02 | D03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 69.06 | 17.25 | 7819 | 5242 | 1.4914 | 1.0993 | MN20160310_N02 | D03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 69.06 | 17.25 | 670 | 5242 | 0.1278 | 0.5585 | MN20160310_N02 | D05 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 69.06 | 17.25 | 8151 | 5242 | 1.5548 | 1.1099 | MN20160310_N02 | D05 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 69.06 | 17.25 | 3 | 5242 | 0.0006 | -0.1911 | MN20160310_N02 | G14 |